EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Articles|September 1, 2006
Easy Freezing of Recalcitrant Keratoses
Application of liquid nitrogen often must be repeated several times when used to treat thick seborrheic keratoses--and still may be ineffective. For an immediate and excellent cosmetic result, try liquid nitrogen for 5 seconds, followed by gentle curettage. Any pinpoint bleeding can be stopped with aluminum chloride.
Advertisement
Application of liquid nitrogen often must be repeated several times when used to treat thick seborrheic keratoses--and still may be ineffective. For an immediate and excellent cosmetic result, try liquid nitrogen for 5 seconds, followed by gentle curettage. Any pinpoint bleeding can be stopped with aluminum chloride.
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
2
Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones
3
Multicomponent Strategies to Ease Vaccination Pain and Fear Across Ages
4
FDA Clears IDE for NeuWire Medical's STROKE-REWIRE Trial in Chronic Ischemic Stroke
5